Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...